Riskpilot← Back to searchSign inGet full accessSkeye Medical AB
ABActiveOrg 5590927611Fridtunavägen 4Medical specialists activities · NACE 8622Est. 20161 employees
Revenue 2025
SEK 1,1M
-65% vs 2024
EBITDA margin
-13.4%
-108% vs 2024
Equity ratio
61.9%
Financial strength
Net profit 2025
SEK 289K
-77% vs 2024
| Revenue | SEK 1,1M | -65% |
| EBITDA | SEK -154K | -108% |
| Net profit | SEK 289K | -77% |
| Total assets | SEK 3,8M | -29% |
| Equity | SEK 2,3M | -21% |
| Employees | 1 | — |
Legal name
Skeye Medical AB
Org number
5590927611
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva konsultverksamhet inom medicin, främst oftalmologi och dermatologi. Aktiebolaget kommer även att hyra ut lokaler samt hantera värdepapper.
Address
Fridtunavägen 4
Email
m.tjornvik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 841 | 3 849 | 2 851 | 3 323 | 1 147 |
| Staff expenses | — | — | −1 078 | — | — |
| EBITDA | 1 572 | 1 488 | 1 554 | 2 049 | −154 |
| Depreciation & amort. | −84 | −70 | — | −0 | −0 |
| EBIT | 1 488 | 1 418 | 1 554 | 2 049 | −154 |
| Net financials | — | −1 | −4 | 7 | 59 |
| Profit before tax | 1 119 | 1 060 | 1 151 | 1 575 | 376 |
| Tax | −245 | −221 | −247 | −337 | −87 |
| Net profit | 874 | 839 | 904 | 1 238 | 289 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 474 | 3 593 | 3 855 | 5 316 | 3 777 |
| Equity | 1 177 | 1 516 | 2 040 | 2 949 | 2 338 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 676 | 1 100 | 440 | 511 | 54 |
| Total debt | 676 | 1 100 | 440 | 511 | 54 |
EBITDA margin
-13.4%
This company
15.8%
Market median
-185% vs market
20212025
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
20212025
Return on equity
12.4%
This company
18.4%
Market median
+33% vs market
20212025
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JM Chief Executive Officer | Chief Executive Officer | 2022 |
BT Audit | Audit | 2022 |
ZT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skeye Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Mathias Tjörnvik | Chief Executive Officer | 0 companies |
| Bengt Tommy Jonasson | Audit | 0 companies |
| Zeynep Tüysüz Tjörnvik | Deputy Chief Executive Officer | 0 companies |